ArticleFrontiers in immunology2025

The efficacy and safety of adjuvant immunotherapy after neoadjuvant immunotherapy combined with chemotherapy in locally advanced resectable esophageal squamous cell carcinoma: a real-world study.

Xue Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.